Enterobacteriaceae can cause a wide variety of infections ranging from gastrointestinal syndromes to urinary tract infections. These infections have significant mortality rates. Many classes of antibiotics are used to treat these infections. In particular, third-generation cephalosporins are used as part of empiric treatment world-wide in case of severe infections that may be caused by Enterobacteriaceae. The emergence of multi-resistant Enterobacteriaceae, especially those carrying extended-spectrum beta-lactamases (ESBLs) and carbapenemases pose a threat to public health. In chapter 2, 3, and 4 new new detection methods of ESBLs are described. In chapter 5 a bacterial typing method is evaluated. In chapter 6 are the previously described t...
Objective. Determine the prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteria...
In human medicine, the most important family of bacteria is Enterobacteriaceae, which includes gener...
The spread of multidrug-resistant Enterobacteriaceae is complicating the treatment of nosocomial inf...
The rising prevalence of extended-spectrum beta-lactamase (ESBL-)producing Enterobacteriaceae threat...
Enterobacteriaceae belong to the normal enteric flora in humans and may cause infections. Escherichi...
Abstract: Extended-spectrum b-lactamase (ESBL)-producing Enterobacteriaceae with Cefotaximase–Münche...
The growing use of broad-spectrum cephalosporins in recent years resulted in the appearance of the E...
AbstractAntibiotic resistance is a problem of deep scientific concern both in hospital and community...
This paper describes the trends in prevalence of ESBL producing Enterobacteriaceae (ESBL-E) and ESBL...
The emergence and spread of resistance in Enterobacteriaceae is a growing concern in human medicine ...
Type: BacteriaAlso known as: Extended-spectrum \u3b2-lactamaseAbout: ESBL-producing Enterobacteriace...
In 271 Enterobacter blood culture isolates from 12 hospitals, extended-spectrum beta-lactamase (ESBL...
Extended spectrum beta-lactamases (ESBLs) are enzymes produced by bacteria, mostly members of the fa...
The production of β-lactamase is the principal mechanism by which gram-negative bacteria resist the ...
Extended-spectrum b-lactamases (ESBLs) produced by Klebsiella pneumoniae, Escherichia coli, Proteus ...
Objective. Determine the prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteria...
In human medicine, the most important family of bacteria is Enterobacteriaceae, which includes gener...
The spread of multidrug-resistant Enterobacteriaceae is complicating the treatment of nosocomial inf...
The rising prevalence of extended-spectrum beta-lactamase (ESBL-)producing Enterobacteriaceae threat...
Enterobacteriaceae belong to the normal enteric flora in humans and may cause infections. Escherichi...
Abstract: Extended-spectrum b-lactamase (ESBL)-producing Enterobacteriaceae with Cefotaximase–Münche...
The growing use of broad-spectrum cephalosporins in recent years resulted in the appearance of the E...
AbstractAntibiotic resistance is a problem of deep scientific concern both in hospital and community...
This paper describes the trends in prevalence of ESBL producing Enterobacteriaceae (ESBL-E) and ESBL...
The emergence and spread of resistance in Enterobacteriaceae is a growing concern in human medicine ...
Type: BacteriaAlso known as: Extended-spectrum \u3b2-lactamaseAbout: ESBL-producing Enterobacteriace...
In 271 Enterobacter blood culture isolates from 12 hospitals, extended-spectrum beta-lactamase (ESBL...
Extended spectrum beta-lactamases (ESBLs) are enzymes produced by bacteria, mostly members of the fa...
The production of β-lactamase is the principal mechanism by which gram-negative bacteria resist the ...
Extended-spectrum b-lactamases (ESBLs) produced by Klebsiella pneumoniae, Escherichia coli, Proteus ...
Objective. Determine the prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteria...
In human medicine, the most important family of bacteria is Enterobacteriaceae, which includes gener...
The spread of multidrug-resistant Enterobacteriaceae is complicating the treatment of nosocomial inf...